JSK Therapeutics
Sandy, US · Delaware corporation · 1 known investors
JSK Therapeutics is a privately held drug development company working on pharmaceutical products, with funding tied to cancer-related research grants. It has received awards from the National Cancer Institute and backing from seed funds, state technology boards, and angel investors.
Founders & leadership
PS
Paul ShamiNamed on SEC filing
RP
Randall PetersonNamed on SEC filing
DP
Dinesh PatelNamed on SEC filing
JO
Jason OckeyNamed on SEC filing
DJ
Dr. Joseph NowoslawskiNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$962.8K disclosed across 1 round · 2017
▶$962.8KraisedDec 2017 · 10 investors · Other TechnologyRule 506(b)
▶$962.8KraisedDec 2017 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Paul ShamiExecutive Officer, Director
- Randall PetersonDirector
- Dinesh PatelDirector
- Jason OckeyDirector
- Dr. Joseph NowoslawskiExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $962.8K
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does JSK Therapeutics do?
- JSK Therapeutics is a privately held drug development company working on pharmaceutical products, with funding tied to cancer-related research grants. It has received awards from the National Cancer Institute and backing from seed funds, state technology boards, and angel investors.
- Who are JSK Therapeutics's investors?
- JSK Therapeutics's investors include Kickstart.
- How much funding has JSK Therapeutics raised?
- JSK Therapeutics has disclosed $962.8K raised across 1 round.
- Where is JSK Therapeutics headquartered?
- JSK Therapeutics is headquartered in Sandy, US.